Mersana Therapeutics Inc (MRSN)
2.07
-0.15
(-6.76%)
USD |
NASDAQ |
Jun 14, 16:00
2.075
0.00 (0.00%)
After-Hours: 20:00
Mersana Therapeutics Total Assets (Quarterly): 198.37M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 198.37M |
December 31, 2023 | 226.06M |
September 30, 2023 | 262.90M |
June 30, 2023 | 311.00M |
March 31, 2023 | 296.20M |
December 31, 2022 | 334.34M |
September 30, 2022 | 314.85M |
June 30, 2022 | 252.35M |
March 31, 2022 | 258.27M |
December 31, 2021 | 206.11M |
September 30, 2021 | 217.59M |
June 30, 2021 | 253.68M |
March 31, 2021 | 247.91M |
December 31, 2020 | 273.40M |
September 30, 2020 | 290.13M |
Date | Value |
---|---|
June 30, 2020 | 310.52M |
March 31, 2020 | 95.86M |
December 31, 2019 | 107.54M |
September 30, 2019 | 121.66M |
June 30, 2019 | 139.38M |
March 31, 2019 | 149.39M |
December 31, 2018 | 78.50M |
September 30, 2018 | 94.38M |
June 30, 2018 | 106.91M |
March 31, 2018 | 115.76M |
December 31, 2017 | 130.72M |
September 30, 2017 | 142.92M |
June 30, 2017 | 85.22M |
March 31, 2017 | 95.01M |
December 31, 2016 | 105.09M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
95.86M
Minimum
Mar 2020
334.34M
Maximum
Dec 2022
235.91M
Average
253.02M
Median
Total Assets (Quarterly) Benchmarks
Amicus Therapeutics Inc | 721.79M |
Insmed Inc | 1.159B |
Altimmune Inc | 188.36M |
InfuSystems Holdings Inc | 104.85M |
Anavex Life Sciences Corp | 144.52M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 170.39M |
Shareholders Equity (Quarterly) | 27.98M |
Debt to Equity Ratio | 0.9043 |
Current Ratio | 3.512 |
Net Debt Paydown Yield | -0.01% |